Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh ...

Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval. 2 "The burden of Crohn's disease on patients' ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in ...

FAIRFIELD – Susan A. Moroney, 52, passed away quietly on Jan. 9, 2025, at Maine General Medical Center, surrounded by her ...

Listen and subscribe to Morningstar’s The Long View from your mobile device: Apple Podcasts | Spotify (Please stay tuned for ...

Ferne McCann's fiance and her mum reportedly gave each other a frosty reception as they sat side by side in the studio ...

"Eli Lilly Cuts 4Q Sales Outlook After Sluggish Growth for Incretin Drugs," published at 10:06 a.m. ET, incorrectly said the outlook was around $400 below the low end of its last estimated range ...

Shares of Eli Lilly and Co. slipped 0.4% in premarket trading Tuesday, after the drug maker provided a disappointing fourth-quarter revenue outlook, citing slower-than-expected growth in sales of its ...

Amelia Bloomer feared that she would be remembered for a momentary fashion faux pas rather than for her critical work as a ...

Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”). The Biotech ...